172 related articles for article (PubMed ID: 12547996)
21. Effects of the iron chelator deferiprone and the T-type calcium channel blocker efonidipine on cardiac function and Ca
Khamseekaew J; Kumfu S; Palee S; Wongjaikam S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
Cell Calcium; 2018 Jun; 72():18-25. PubMed ID: 29748130
[TBL] [Abstract][Full Text] [Related]
22. Effect of efonidipine, a novel dihydropyridine derivative, on myocardial metabolic changes induced by coronary artery ligation in dogs: comparison with nifedipine.
Yokoyama T; Ichihara K; Abiko Y
Fundam Clin Pharmacol; 1997; 11(3):245-51. PubMed ID: 9243256
[TBL] [Abstract][Full Text] [Related]
23. Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.
Furukawa T; Miura R; Honda M; Kamiya N; Mori Y; Takeshita S; Isshiki T; Nukada T
Br J Pharmacol; 2004 Dec; 143(8):1050-7. PubMed ID: 15545287
[TBL] [Abstract][Full Text] [Related]
24. Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
Okayama S; Imagawa K; Naya N; Iwama H; Somekawa S; Kawata H; Horii M; Nakajima T; Uemura S; Saito Y
Hypertens Res; 2006 Jul; 29(7):493-7. PubMed ID: 17044661
[TBL] [Abstract][Full Text] [Related]
25. Effects of efonidipine hydrochloride on renal arteriolar diameters in spontaneously hypertensive rats.
Nakamura M; Notoya M; Kohda Y; Yamashita J; Takashita Y; Gemba M
Hypertens Res; 2002 Sep; 25(5):751-5. PubMed ID: 12452329
[TBL] [Abstract][Full Text] [Related]
26. Effects of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: an uncontrolled, open-label pilot study.
Shimizu M; Ogawa K; Sasaki H; Uehara Y; Otsuka Y; Okumura H; Kusaka M; Hasuda T; Yamada T; Mochizuki S
Curr Ther Res Clin Exp; 2003 Nov; 64(9):707-14. PubMed ID: 24944418
[TBL] [Abstract][Full Text] [Related]
27. Effects of S(+)-efonidipine on the rabbit sinus node action potential and calcium channel subunits Ca(V)1.2, Ca(V)1.3 and Ca(V)3.1.
Tanaka H; Namekata I; Ogawa T; Tsuneoka Y; Komikado C; Takahara A; Iida-Tanaka N; Izumi-Nakaseko H; Tsuru H; Adachi-Akahane S
Eur J Pharmacol; 2010 Dec; 649(1-3):263-7. PubMed ID: 20858482
[TBL] [Abstract][Full Text] [Related]
28. Effects of diltiazem retard on ambulatory blood pressure and heart rate variability in patients with essential hypertension.
Kawano Y; Makino Y; Okuda N; Takishita S; Omae T
Blood Press Monit; 2000 Jun; 5(3):181-5. PubMed ID: 10915232
[TBL] [Abstract][Full Text] [Related]
29. The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium.
Tanaka H; Komikado C; Shimada H; Takeda K; Namekata I; Kawanishi T; Shigenobu K
J Pharmacol Sci; 2004 Dec; 96(4):499-501. PubMed ID: 15599089
[TBL] [Abstract][Full Text] [Related]
30. Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
Ishimitsu T; Kameda T; Akashiba A; Takahashi T; Ohta S; Yoshii M; Minami J; Ono H; Numabe A; Matsuoka H
Hypertens Res; 2007 Jul; 30(7):621-6. PubMed ID: 17785930
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of efonidipine hydrochloride on contraction induced by several vasoconstrictors in porcine coronary artery: comparison with effects of nifedipine and nisoldipine.
Higashino R; Sato R; Jin H; Inoue N; Fukuta Y; Kurimoto T; Tamaki H
J Cardiovasc Pharmacol; 1997 May; 29(5):624-30. PubMed ID: 9213205
[TBL] [Abstract][Full Text] [Related]
32. Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients.
Nakano N; Ishimitsu T; Takahashi T; Inada H; Okamura A; Ohba S; Matsuoka H
Int Heart J; 2010 May; 51(3):188-92. PubMed ID: 20558909
[TBL] [Abstract][Full Text] [Related]
33. Frequency-dependent blockade of T-type Ca2+ current by efonidipine in cardiomyocytes.
Masumiya H; Kase J; Tanaka Y; Tanaka H; Shigenobu K
Life Sci; 2000 Dec; 68(3):345-51. PubMed ID: 11191650
[TBL] [Abstract][Full Text] [Related]
34. Effects of efonidipine hydrochloride on cholesterol esterification mediated by beta-very low density lipoprotein in J774 macrophages.
Kitahara M; Toyoda K; Yamashita T; Sakashita M; Tanaka S; Saito Y
Jpn J Pharmacol; 1995 Oct; 69(2):101-9. PubMed ID: 8569046
[TBL] [Abstract][Full Text] [Related]
35. Beneficial effects of the dual L- and T-type Ca2+ channel blocker efonidipine on cardiomyopathic hamsters.
Suzuki S; Ohkusa T; Ono K; Sato T; Yoshida MA; Yano M; Takebayashi S; Matsuzaki M
Circ J; 2007 Dec; 71(12):1970-6. PubMed ID: 18037756
[TBL] [Abstract][Full Text] [Related]
36. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
[TBL] [Abstract][Full Text] [Related]
37. Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice.
Khamseekaew J; Kumfu S; Wongjaikam S; Kerdphoo S; Jaiwongkam T; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
Eur J Pharmacol; 2017 Mar; 799():118-127. PubMed ID: 28192097
[TBL] [Abstract][Full Text] [Related]
38. Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodelling during atrial fibrillation.
Ohashi N; Mitamura H; Ogawa S
Drugs; 2009; 69(1):21-30. PubMed ID: 19192934
[TBL] [Abstract][Full Text] [Related]
39. [Effect of efonidipine hydrochloride (NZ-105) on modification of low density lipoprotein induced by rat cultured endothelial cells].
Ito S; Higashino R; Tanaka T; Takei M; Kurimoto T; Matsuda K
Nihon Yakurigaku Zasshi; 1995 Oct; 106(4):263-70. PubMed ID: 8537073
[TBL] [Abstract][Full Text] [Related]
40. Influence of efonidipine hydrochloride, calcium antagonist on the epithelium of prostates in spontaneously hypertensive rats.
Furukawa S; Yamamoto O; Tamura T; Masuda Y; Shudo C; Hayashi K; Hirata H
J Toxicol Sci; 1994 Nov; 19(4):213-7. PubMed ID: 7884832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
